Skip to content

Diagnostic Biomarkers for Cognitive Disorders in China: Longitudinal Prospective Cohort Studies

Diagnostic Biomarkers for Cognitive Disorders in China: Longitudinal Prospective Cohort Studies

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102359
Enrollment
Unknown
Registered
2025-05-13
Start date
2024-06-30
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjective cognitive disorder

Interventions

Dementia progression:None
Dementia stabilization:None

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Male or female patients aged >=40 and <=90years; 2.Chief complaint or others describe a cognitive decline; 3.Ability to communicate in Chinese; 4.The patients and their families were informed and signed the informed consent;

Exclusion criteria

Exclusion criteria: 1.MMSE<10; 2.There are other neurological diseases that can cause brain dysfunction (such as depression, brain tumors, Parkinson’s disease disease, metabolic encephalopathy, encephalitis, multiple sclerosis, epilepsy, traumatic brain injury, normal intracranial pressure hydrocephalus, etc.); 3.There are other systemic diseases that can cause cognitive impairment (such as hepatic insufficiency, renal insufficiency, Thyroid dysfunction, severe anemia, folic acid or vitamin B12 deficiency, syphilis, HIV infection, alcohol and drug abuse, etc.); 4.Suffering from a disease that cannot cooperate with the completion of cognitive examination; 5.There are contraindications to nuclear magnetic resonance; 6.There is mental and neurodevelopmental delay; 7.Refuse to draw blood;

Design outcomes

Primary

MeasureTime frame
Clinical Dementia Rating (CDR);

Secondary

MeasureTime frame
Simple Mental State Examination Scoring;Montreal Cognitive Assessment Score;Alzheimer's Disease Assessment Scale-Cognitive section (ADAS-cog);World Health Organization-University of California, Los Angeles, auditory verbal learning test (WHO-UCLA AVLT);Boston Naming Test (BNT);Neuropsychiatric scale scoring;Alzheimer's Disease Cooperative Study-Activity of Daily Living (ADCS-ADL);

Countries

China

Contacts

Public ContactCuibai Wei

Xuanwu Hospital Capital Medical University

weicb@xwhosp.org+86 10 83198333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026